BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 431 filers reported holding BIO-TECHNE CORP in Q4 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $945,105 | -14.9% | 13,884 | +2.0% | 0.07% | -12.2% |
| Q2 2023 | $1,110,903 | +11.2% | 13,609 | +1.1% | 0.08% | +6.5% |
| Q1 2023 | $999,117 | -13.6% | 13,467 | -3.5% | 0.08% | -28.7% |
| Q4 2022 | $1,156,259 | +20.2% | 13,951 | +311.7% | 0.11% | +16.1% |
| Q3 2022 | $962,000 | -17.3% | 3,389 | +1.0% | 0.09% | -18.4% |
| Q2 2022 | $1,163,000 | -20.6% | 3,356 | -0.8% | 0.11% | -17.4% |
| Q1 2022 | $1,465,000 | -16.8% | 3,384 | -0.5% | 0.14% | -4.8% |
| Q4 2021 | $1,760,000 | +12.7% | 3,402 | +5.6% | 0.14% | +4.3% |
| Q3 2021 | $1,561,000 | +8.4% | 3,222 | +0.7% | 0.14% | +6.1% |
| Q2 2021 | $1,440,000 | +17.8% | 3,199 | 0.0% | 0.13% | -2.2% |
| Q1 2021 | $1,222,000 | +20.2% | 3,199 | -0.1% | 0.13% | +15.5% |
| Q4 2020 | $1,017,000 | +30.7% | 3,202 | +2.0% | 0.12% | +9.4% |
| Q3 2020 | $778,000 | -5.0% | 3,139 | +1.3% | 0.11% | -13.8% |
| Q2 2020 | $819,000 | +39.3% | 3,100 | 0.0% | 0.12% | +10.8% |
| Q1 2020 | $588,000 | -13.4% | 3,100 | +0.2% | 0.11% | -8.3% |
| Q4 2019 | $679,000 | +12.0% | 3,095 | 0.0% | 0.12% | +2.5% |
| Q3 2019 | $606,000 | -7.6% | 3,095 | -1.6% | 0.12% | -7.8% |
| Q2 2019 | $656,000 | +5.1% | 3,145 | 0.0% | 0.13% | +5.8% |
| Q1 2019 | $624,000 | +37.1% | 3,145 | 0.0% | 0.12% | +15.2% |
| Q4 2018 | $455,000 | -29.1% | 3,145 | 0.0% | 0.10% | -19.8% |
| Q3 2018 | $642,000 | +38.1% | 3,145 | 0.0% | 0.13% | +33.7% |
| Q2 2018 | $465,000 | -2.1% | 3,145 | 0.0% | 0.10% | -3.0% |
| Q1 2018 | $475,000 | +8.0% | 3,145 | 0.0% | 0.10% | +17.4% |
| Q4 2017 | $440,000 | +17.3% | 3,145 | +1.5% | 0.09% | +10.3% |
| Q3 2017 | $375,000 | +3.0% | 3,099 | 0.0% | 0.08% | -3.7% |
| Q2 2017 | $364,000 | +24.2% | 3,099 | 0.0% | 0.08% | +17.4% |
| Q1 2016 | $293,000 | +2.4% | 3,099 | 0.0% | 0.07% | -77.7% |
| Q4 2014 | $286,000 | – | 3,099 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ownership Capital B.V. | 972,263 | $308,742,000 | 4.35% |
| Sandhill Capital Partners LLC | 138,864 | $44,096,000 | 4.03% |
| STONE RUN CAPITAL, LLC | 27,350 | $8,685,000 | 3.45% |
| DF DENT & CO INC | 925,823 | $293,995,000 | 3.42% |
| Brown Capital Management | 1,498,233 | $475,764,000 | 3.29% |
| MAIRS & POWER INC | 848,081 | $269,308,000 | 2.99% |
| Summit Creek Advisors LLC | 64,179 | $20,380,000 | 2.62% |
| GENEVA CAPITAL MANAGEMENT LLC | 402,958 | $127,959,000 | 2.17% |
| Aristotle Atlantic Partners, LLC | 86,993 | $27,625,000 | 2.13% |
| CROWN ADVISORS MANAGEMENT, INC. | 8,000 | $2,540,000 | 1.82% |